Becton Dickinson recalls BD PrecisionGlide 30G needles with blood contamination risk. If blood is not noticed before use, infection may occur. Affected units: Lot 9128897, expired June 2024.
BD has confirmed the presence of blood on the cannulas of the BD PrecisionGlide needles 30G X 1/2" Lot No. 9128897. The possibility of infection may be present if the blood is not noticed prior to use by the clinician.
Take action
Contact the company
📍Recalling firmBecton Dickinson & Company1 Becton Dr · Franklin Lakes, NJ 07417-1815
“BD PrecisionGlide Needle 30G Recall: Blood Contamination Risk.” GovInfoNow, updated August 19, 2026. https://govinfonow.com/recall/63883-bd-precisionglide-needle-30g-recall-blood-contamination-risk. Based on FDA recall #Z-0588-2021 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-0588-2021%22&limit=1).
Becton Dickinson & Company recalled BD PrecisionGlide Needles due to the presence of blood on cannulas, which may pose an infection risk. The Food and Drug Administration announced this Class II recall on November 18, 2020.
How to tell if you have it
Brand: Becton Dickinson
Product: BD PrecisionGlide Needle 30G x 1/2 (0.3 mm X 13mm)
REF: 305106
Lot No.: 9128897
Expiration Date: 2024-06-30
UDI: 30382903051060
The hazard
BD has confirmed the presence of blood on the cannulas of the recalled needles. The possibility of infection may be present if the blood is not noticed prior to use by the clinician.
Context
GovInfoNow's records show Becton Dickinson & Company has 52 other recalls on record since May 31, 2017. Other recent recalls of similar products include Medline Perfusion Syringe Recall (October 27, 2025), B Braun Medical Blood Set Recall (October 29, 2025), and B. Braun 21G Winged Infusion Needle Recall (February 2, 2026).
How to tell if you have this one
Check for lot number 9128897 on the packaging. The needles are 30G x 1/2 inch (0.3 mm x 13mm) with catalog reference 305106. They expired June 2024.
Brand
Becton Dickinson
Category
Medical device
Based on the official FDA remedy
What to do — step by step
Check for Blood Contamination
Inspect the needle for visible blood before use. If blood is present, do not use the needle.
Where it went and when
Where it was distributed
Distributed nationwide and abroad; the notice names 13 states.
Named in the notice
Covered by “nationwide”
Not listed
FDA distribution: “Worldwide distribution - US Nationwide distribution including in the states of CA, CT, FL, IL, KY, MO, NJ, NY, OH, PA, PR, SC, TN, VA and the countries of Canada, China, Singapore.” States read from FDA’s own wording; “not listed” means the notice does not name it.
Named in the notice: California, Connecticut, Florida, Illinois, Kentucky, Missouri, New Jersey, New York, Ohio, Pennsylvania, Puerto Rico, South Carolina, Tennessee, Virginia.
Recall timeline
FDA terminated this recall 3.2 years after the firm started it.
1Firm started the recall
2FDA classified it Class II
3Published in FDA’s Enforcement Report
4FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #Z-0588-2021 (November 18, 2020) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-0588-2021 to see it in context.
Plain-language summary written by qwen3:4b on August 19, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.